The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2026
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Samartcev I.N.

Kirov Military Medical Academy

Zhivolupov S.A.

Kirov Military Medical Academy

Medical adherence as the basis for effective therapy — current state of the art

Authors:

Samartcev I.N., Zhivolupov S.A.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2021;121(12): 51‑56

DOI: 10.17116/jnevro202112112151

Read: 2437 times

Download PDF (RU)
Contact the author
Table of contents

MEDICAL ADHERENCE AS THE BASIS FOR EFFECTIVE THERAPY — CURRENT STATE OF THE ART
MEDICAL ADHERENCE AS THE BASIS FOR EFFECTIVE THERAPY — CURRENT STATE OF THE ART

To cite this article:

Samartcev IN, Zhivolupov SA. Medical adherence as the basis for effective therapy — current state of the art. S.S. Korsakov Journal of Neurology and Psychiatry. 2021;121(12):51‑56. (In Russ.)
https://doi.org/10.17116/jnevro202112112151

Подписка 2026 Журнал неврологии и психиатрии им. С.С. Корсакова (S.S. Korsakov Journal of Neurology and Psychiatry)
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Cere­brovascular disease in clinical practice. Reso­lution of the Expert Council of the Russian Scientific Medi­cal Society of Therapists. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(6):105-111
Obje­ctive Moni­toring of Compliance with Compression Treatment in Patients with Chro­nic Venous Disease is Better than Self-Reported Using Patient’s Diary. Journal of Venous Diso­rders. 2025;(2):113-119
Features of the inte­rpretation of bodily sensations by patients with arte­rial hype­rtension. Russian Journal of Preventive Medi­cine. 2025;(10):82-87
Analysis of the prevalence of musculoskeletal system pathologies among workers of a heavy indu­stry ente­rprise. Russian Journal of Preventive Medi­cine. 2025;(12):52-59
The role of the Diabetes School in increasing compliance of patients with type 2 diabetes to treatment and improving glycemic control. Russian Journal of Preventive Medi­cine. 2026;(1):47-53
Abstract:

OBJECTIVE

The study was to assess the importance of the problem of medical adherence (MA) among therapists in St. Petersburg (2021).

MATERIAL AND METHODS

The study involved 96 doctors of various therapeutic specialties (neurologists, therapists and rheumatologists), who were asked to respond to an original questionnaire concerning MA, that was designed in neurology department of Military Medical academy n.a. S.M. Kirov, St. Petersburg It was found that, according to experts, the main negative factors that significantly decreases MA are the high cost of the drug (40.1%) and polypharmacy (22.1%); the main property of the drug associated with high MA is the convenience of taking it — once a day (51.1%). Such drugs include, for example, a new form of the muscle relaxant tolperisone hydrochloride prolonged release 450 mg.

RESULTS AND CONCLUSIONS

According to experts, the main negative factors that significantly reduce MA are the high cost of the drug (40.1%) and polypharmacy (22.1%); the main property of the drug associated with high MA on the part of patients is the convenience of its administration — 1 once a day (51.1%). Such drugs include, for example, a new form of release of the muscle relaxant tolperisone hydrochloride prolonged release 450 mg.

CONCLUSIONS

A systematic approach is required to improve MA, carried out both at the state level (changing public consciousness, financing systems, etc.) and in tandem doctor-patient (moving away from paternalistic medicine, prescribing depot forms of drugs, etc.).

Keywords:

medical adherence
compliance
OPTIMUS study

Authors:

Samartcev I.N.

Kirov Military Medical Academy

Zhivolupov S.A.

Kirov Military Medical Academy

Received:

05.10.2021

Accepted:

16.10.2021

Close metadata

References:

  1. Nenasheva NM. Vozmozhnosti dostizheniya kontrolya nad bronhialnoj astmoj v usloviyakh klinicheskoj praktike. Atmosfera. Pulmonologia i allergilogia. 2007;1:36-39 (In Russ.).
  2. Erlich AD, Gracianskij NA. i uchastniki registra Rekord. Lechenije bolnykh s osrtym koronarnym sindromom v statsionarakh imejushikh i ne imejushikh vozmozhnosti vypolnenija invazivnikh koronarnikh protsedur. 2010;7:8-20. (In Russ.).
  3. Goldsmith CH. The effect of compliance distributions on therapeutic trials. In: Haynes R.B., Taylor D.W., Sackett D.L., eds. Compliance in HealthCare. Baltimore: John Hopkins University Press; 1979.
  4. Adherence to long-term therapies: evidence for action. World Health Organization; 2003. Accessed: 06 Apr 2013. https://www.who.int/chp/knowledge/publications/adherence/report/en/
  5. Horne R. Compliance, adherence, and concordance: implications for asthma treatment. Chest. 2006;130(1 suppl):65-72.  https://doi.org/10.1378/chest.130.1_suppl.65S
  6. Molotkov AO, Punin AA, Molotkova SA, Evseeva IP. Komplaence ili priverzhennost terapii: sovremennoje sostojanie problemy i osobennosti pri bronhialnoj astme. Vestnik Smolenskoj gosudarstvennoj meditsinskoj akademii. 2012;1:56. (In Russ.).
  7. Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986;24(1):67-74. PMID: 3945130. https://doi.org/10.1097/00005650-198601000-00007
  8. Konradi AO. Znachenije priverzhennosti k terapii v lechenii kardiologicheskikh zabolevanij. Spravochnik poliklinicheskogo vracha. 2007;(6):8-12. (In Russ.).
  9. Claxton AJ, Cramer J, Pierce C. A systematic review of the associations between dose regimens and medication compliance. Clin Ther. 2001;23:1296-1310. https://doi.org/10.1016/s0149-2918(01)80109-0
  10. Bosley C, Fosbury J, Cochrane G. The psychological factors associated with poor compliance with treatment in asthma. Eur Resp J. 1995;8:899-904. PMID: 7589375.
  11. Mendelevich VD. Klinicheskaya I medicinskaja psikhologia: Praklich. rukovodstvo. M.: Medpress; 2001. (In Russ.).
  12. Eisen S, Miller D, Woodward R, Spitznagel E, Przybeck T. The effect of prescribed daily dose frequency on patient medication compliance. Arch Intern Med. 1990;150:1881-1884. PMID: 2102668.
  13. Granger B, Ekman I, Granger C, et al. Adherence to medication according to sex and age in the CHARM programme. Eur J Heart Fail. 2009;11(11):1092-1098. https://doi.org/10.1093/eurjhf/hfp142
  14. Keating N, Gandhi T, Orav E, Bates D, Ayanian J. Patient characteristics and experiences associated with trust in specialist physicians. Arch Intern Med. 2004;164(9):1015-1020. https://doi.org/10.1001/archinte.164.9.1015
  15. Mosolov SN. Sovremenny etap razvitiya psikhofarmakoterapii. Russkij meditsinskij zhurnal. 2002;10(12-13):45-49. (In Russ.).
  16. Jimmy B, Jose J. Patient medication adherence: measures in daily practice. Oman Med J. 2011;26(3):155-159.  https://doi.org/10.5001/omj.2011.38
  17. Cramer J. Identifying and improving compliance patterns. In: Cramer JA, Spilker B, eds. Patient compliance in medical practice and clinical trials. New York: Raven Press; 1991;387-392. 
  18. Sokolova TV, Davidenko MS, Malyarchuk AP. Is it possible to identify compliance and adherence to therapy? Experts opinion. Russian Journal of Skin and Venereal Diseases. 2020;23:3:174-181. (In Russ.). https://doi.org/10.17816/dv48902
  19. Cramer J. Identifying and improving compliance patterns. In: Cramer JA, Spilker B, eds. Patient compliance in medical practice and clinical trials. New York: Raven Press; 1991.
  20. Dzhakubekova AU, Kazymbekov KP. Sovremennoje sostoyanie problemy priverzhennosti patsienta lecheniyu (obzor). Vestnik KGMA im. I.K. Akhundaeva. 2012;(4):42-47. (In Russ.).
  21. Coleman C, Limone B, Sobieraj D, et al. Dosing frequency and medication adherence in chronic disease. J Manag Care Pharm. 2012;18(7):527-539.  https://doi.org/10.18553/jmcp.2012.18.7.527
  22. European Medicines Agency (2020). Guideline on the pharmacokinetic and clinical evaluation of modified release dosage forms. https://www.ema.europa.eu/en/documents/scientific-guideline/guideline-pharmacokinetic-clinical-evaluation-modified-release-dosage-forms_en.pdf
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.